|
Name |
CAS No. |
Usage |
Status |
|
Eltrombopag Olamine 艾曲波帕乙醇胺 |
496775-62-3 |
Low Blood Platelet Count 血小板减少症 |
US DMF 38914 CN Status: A CDE Registration No.:Y20230000603 |
|
Trametinib (DMSO) 曲美替尼二甲亚砜 |
1187431-43-1 |
Melanoma 黑色素瘤 |
CMC Completed |
|
Dabrafenib Mesylate 达拉芬尼甲磺酸盐 |
1195768-06-9 |
Melanoma 黑色素瘤 |
US DMF 043177 CDE Registration No.:Y20250000940 |
|
Ibrutinib (Form A) 伊布替尼 (晶型A) |
936563-96-1 |
CLL/MCL 白血病&套细胞淋巴瘤 |
CDE Registration No.: Y20230001268 |
|
Tepotinib Hydrochloride 特泊替尼盐酸盐 |
1100598-32-0 1946826-82-9 |
NSCLC 非小细胞肺癌 |
CDE Registration No.: Y20250001190 |
|
Etrasimod Arginine 精氨酸伊曲莫德 |
1206123-37-6 1206123-97-8 |
Ulcerative Colitis (UC) 溃疡性结肠炎 |
CMC Completed Under Validation |
|
Fezolinetant 非唑奈坦 |
1629229-37-3 |
VMS Caused by Menopause 更年期潮热 |
CMC Completed Under Validation |
|
Sparsentan 司帕生坦 |
254740-64-2 |
IgA Nephropathy Ig A 肾病 |
Pilot |
|
Maralixibat HCl 氯马昔巴特 |
228113-66-4 |
Cholestatic Itching 胆汁淤积性瘙痒 |
Kilo |
|
Capivasertib 卡帕塞替尼 |
1143532-39-1 |
Breast Cancer 乳腺癌 |
Pilot |
|
Duvelisib 度维利塞 |
1201438-56-3 |
CLL/FL 白血病&滤泡性淋巴瘤 |
Under R&D |
|
Gepotidacin 吉泊达星甲磺酸盐二水合物 |
1624306-20-2 |
Gonorrhea 泌尿生殖道淋病 |
Pilot |
|
氟比洛芬 Flurbiprofen |
5104-49-4 |
Arthritis 关节炎 |
Under Evaluation |